LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "gov identifier" as a keyword



Photo by zenmaldives from unsplash

The NK1 receptor antagonist serlopitant for treatment of chronic pruritus

Sign Up to like & get
recommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"

DOI: 10.1080/13543784.2019.1638910

Abstract: ABSTRACT Introduction: Pruritus is a common symptom associated with several potential underlying causes, including both dermatologic and systemic diseases; it can also occur without an identifiable cause. Current treatment options are limited and most patients… read more here.

Keywords: trial registration; clinicaltrials gov; gov identifier; registration clinicaltrials ... See more keywords
Photo by zenmaldives from unsplash

Investigational drugs in early-stage clinical trials for autism spectrum disorder

Sign Up to like & get
recommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"

DOI: 10.1080/13543784.2019.1649656

Abstract: ABSTRACT Introduction: Pharmacologic interventions in Autism Spectrum Disorder (ASD) have historically focused on symptom-based approaches. However, a treatment for the core social deficits has remained unidentified. While a definitive theory for the cause of ASD… read more here.

Keywords: trial registration; clinicaltrials gov; gov identifier; registration clinicaltrials ... See more keywords
Photo by zenmaldives from unsplash

Current and emerging biologics for the treatment of hereditary angioedema

Sign Up to like & get
recommendations! Published in 2019 at "Expert Opinion on Biological Therapy"

DOI: 10.1080/14712598.2019.1595581

Abstract: ABSTRACT Introduction: Hereditary angioedema due to C1-INH deficiency (C1-INH-HAE) is a rare disease with unpredictable, self-limiting and localized swelling episodes involving the cutaneous and subcutaneous tissues. In the last decade, the spectrum of the possibilities… read more here.

Keywords: trial registration; clinicaltrials gov; gov identifier; registration clinicaltrials ... See more keywords
Photo by joshuas from unsplash

Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia

Sign Up to like & get
recommendations! Published in 2022 at "Hematology"

DOI: 10.1080/16078454.2022.2074704

Abstract: ABSTRACT Objectives This review aims to see the progress of several clinically-used monoclonal antibodies in treating ALL patients and how they improved patients' outcomes. Methods We searched Web of Science, Elsevier and PubMed for relevant… read more here.

Keywords: gov identifier; clinicaltrials gov; registration clinicaltrials; trial registration ... See more keywords
Photo by zenmaldives from unsplash

Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability

Sign Up to like & get
recommendations! Published in 2019 at "Expert Opinion on Drug Delivery"

DOI: 10.1080/17425247.2019.1567490

Abstract: ABSTRACT Introduction: Treatment of several diseases of the brain are complicated by the presence of the skull and the blood-brain barrier (BBB). Focused ultrasound (FUS) and microbubble (MB)-mediated BBB treatment is a minimally invasive method… read more here.

Keywords: trial registration; clinicaltrials gov; gov identifier; registration clinicaltrials ... See more keywords